| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO - Health Care | Director
2 companies
Davis Jennifer L. is a CEO - Health Care at PROCTER & GAMBLE Co with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $9.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | PG Procter & Gamble Co | CEO - Health Care | Sell | 3,227 | $152.23 | $491,251.70 | -5.0% | -5.7% | - | |
| Aug 19, 2025 | PG Procter & Gamble Co | CEO - Health Care | Sell | 8,596 | $157.27 | $1,351,925.58 | -11.7% | -7.9% | - | |
| Apr 29, 2025 | PG Procter & Gamble Co | CEO - Health Care | Sell | 1,000 | $161.38 | $161,384.00 | -1.9% | -3.2% | - | |
| Oct 2, 2024 | PG Procter & Gamble Co | CEO - Health Care | Sell | 4,447 | $171.65 | $763,345.78 | -7.8% | -2.5% | -11.6% | |
| Aug 20, 2024 | PG Procter & Gamble Co | CEO - Health Care | Sell | 6,223 | $169.22 | $1,053,049.84 | -9.8% | +0.2% | -6.4% | |
| Aug 17, 2023 | PG Procter & Gamble Co | CEO - Health Care | Sell | 5,761 | $152.85 | $880,546.38 | -10.9% | -0.5% | +10.4% | |
| Apr 24, 2023 | PG Procter & Gamble Co | CEO - Health Care | Sale+OE | 23,943 | $155.27 | $3,717,629.61 | -37.5% | -1.9% | +3.3% | |
| Aug 23, 2022 | PG Procter & Gamble Co | CEO - Health Care | Sale+OE | 27,809 | $147.95 | $4,114,341.55 | -45.8% | -0.7% | +5.4% | |
| Aug 17, 2022 | PG Procter & Gamble Co | CEO - Health Care | Sell | 7,621 | $149.33 | $1,138,039.36 | -18.8% | -5.2% | +2.6% |